PRESCRIPTION OF PSYCHOTROPIC DRUGS IN PATIENTS WITH HARMFUL SOCIOECONOMIC AND ENVIRONMENTAL CONDITIONS: A SYSTEMATIC REVIEW.

Authors

  • Matusalém Marcelino Cândido
  • Michelangela Suelleny de Caldas Nobre

DOI:

https://doi.org/10.56083/RCV2N3-038

Keywords:

Psicotrópicos, Condições socioeconômicas, Fatores demográficos

Abstract

Objective: to assist in the improved identification of risk factors and predictors of increased demand for psychotropic drugs in vulnerable populations. Methodology: the present study is a systematic review of the literature, of a qualitative nature, using the Virtual Health Library (BVS) and Medical Publisher (PubMed) databases, aiming to search for articles that answered the guiding question "In psychiatric patients with impaired social, economic and environmental conditions, is there a greater demand for psychotropic drugs?”, comprising the relationship between the prescriptions of these drugs, especially in psychiatric diseases, with the impaired socioeconomic and environmental conditions. Results: there is a relationship of social, environmental and structural factors with the increase in demand for psychotropic medication, mainly according to socioeconomic level, marital status, sex, stress, marital relationship, association of psychiatric disorders, level of education, self-perception of health general, area of ​​residence, unemployment, retirement, comorbidities and ethnicity. Conclusion: The main factors that influenced the demand for psychotropic drugs were socioeconomic level and marital relationship or marital status. It was also shown that from the knowledge of risk factors, predictive measures can be more targeted and effective.

References

ALDUHISHY, M. The overprescription of antidepressants and its impact on the elderly in Australia. Trends in psychiatry and psychotherapy, v. 40,3, p. 241-243, 2018. Disponível em: https://www.scielo.br/j/trends/a/sHyNG94CQsJrmsQyNMNqFxj/?lang=en DOI: https://doi.org/10.1590/2237-6089-2016-0077

ANNEQUIN, M. et al. Environmental and individual characteristics associated with depressive disorders and mental health care use. Annals of epidemiology, v. 25, n. 8, p. 605 – 612, 2015. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25841991/ DOI: https://doi.org/10.1016/j.annepidem.2015.02.002

AUBIN, H. J. et al. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Addiction (Abingdon, England), v. 99, n. 9, p. 1206 – 1218, 2004. Disponível em: https://pubmed.ncbi.nlm.nih.gov/15317642/ DOI: https://doi.org/10.1111/j.1360-0443.2004.00814.x

BAUMANN, M. et al. Associações de privação social e material com uso de tabaco, álcool e drogas psicotrópicas e gênero: um estudo de base populacional. Revista Internacional de Geografia da Saúde, v. 6, n. 1, p. 1 – 12, 2007. Disponível em: https://pesquisa.bvsalud.org/bvsms/resource/pt/mdl-17996098

BENACEK, J. et al. Personality, symptom, and demographic correlates of perceived efficacy of selective serotonin reuptake inhibitor monotherapy among current users with low mood: A data-driven approach. Journal of Affective Disorders, v. 295, p. 1122-1130, 2021. Disponível em: https://www.sciencedirect.com/science/article/pii/S0165032721008934 DOI: https://doi.org/10.1016/j.jad.2021.08.088

BURNETT-ZEIGLER, I. et al. Longitudinal predictors of first time depression treatment utilization among adults with depressive disorders. Social psychiatry and psychiatric epidemiology, v. 47, n. 10, p. 1617 – 1625, 2012. Disponível em: https://pubmed.ncbi.nlm.nih.gov/22218726/ DOI: https://doi.org/10.1007/s00127-011-0465-6

CAROLAN, A. et al. Optimising prescribing for patients with severe mental illness: the need for criteria. Evidence-based mental health, v. 22, n. 4, p. 139-141, 2019. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31511231/ DOI: https://doi.org/10.1136/ebmental-2019-300099

DENTON, W. H. et al. Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. Psychological medicine, v. 40, n. 3, p. 415 – 424, 2010. Disponível em: https://pubmed.ncbi.nlm.nih.gov/19607755/ DOI: https://doi.org/10.1017/S0033291709990535

DONATO, H.; DONATO, M. Etapas na Condução de uma Revisão Sistemática. Acta Médica Portuguesa, v. 32, n. 3, p. 227-235, mar. 2019. Disponível em: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/11923/0 DOI: https://doi.org/10.20344/amp.11923

GALVÃO, T. F.; PEREIRA, M. G. Avaliação da qualidade da evidência de revisões sistemáticas. Epidemiologia e Serviços de Saúde, v. 24, p. 173-175, 2015. Disponível em: http://scielo.iec.gov.br/scielo.php?script=sci_arttext&pid=S1679-49742015000100019 DOI: https://doi.org/10.5123/S1679-49742015000100019

JOUNG, K. et al. Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study. Pharmacoepidemiology and drug safety, v. 28, n. 12, p. 1591 – 1600, 2019. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31692168/ DOI: https://doi.org/10.1002/pds.4902

KASPERSEN, S. L. et al. Unemployment and initiation of psychotropic medication: a case-crossover study of 2 348 552 Norwegian employees. Occupational and environmental medicine, v. 73, n. 11, p. 719 – 726, 2016. Disponível em: https://pubmed.ncbi.nlm.nih.gov/27165811/ DOI: https://doi.org/10.1136/oemed-2016-103578

KROLL, D. S. et al. Benzodiazepines are Prescribed More Frequently to Patients Already at Risk for Benzodiazepine-Related Adverse Events in Primary Care. J gen intern med, v. 31, p. 1027 – 1034, 2016. Disponível em: https://pubmed.ncbi.nlm.nih.gov/27177914/ DOI: https://doi.org/10.1007/s11606-016-3740-0

LIMA, T. N.; SOUSA, M. N. A. Uso abusivo de psicotrópicos e fatores associados com a má utilização na Atenção primária à saúde. Id On Line. Revista de Psicologia, v. 14, n. 54, p. 92-103, 2021. Disponível em: https://idonline.emnuvens.com.br/id/article/view/2915 DOI: https://doi.org/10.14295/idonline.v15i54.2915

MOLLER, J. et al. Widowhood and the risk of psychiatric care, psychotropic medication and all-cause mortality: a cohort study of 658,022 elderly people in Sweden. Aging & mental health, v. 15, n. 2, p. 259 – 266, 2011. Disponível em: https://pubmed.ncbi.nlm.nih.gov/21140303/ DOI: https://doi.org/10.1080/13607863.2010.513041

NG, C. G. et al. Prescription patterns for psychotropic drugs in cancer patients; a large population study in the Netherlands. Psycho-oncology, v. 22, n. 4, p. 762 – 767, 2013. Disponível em: https://pubmed.ncbi.nlm.nih.gov/22351591/ DOI: https://doi.org/10.1002/pon.3056

PASINA, L. et al. Drug prescriptions in nursing home residents: an Italian multicenter observational study. Eur J Clin Pharmacol, v. 76, n. 7, p. 1011-1019, 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32314001/ DOI: https://doi.org/10.1007/s00228-020-02871-7

PRUCHNO, R. A.; POTASHNIK, S. L. Caregiving spouses. Physical and mental health in perspective. Journal of the American Geriatrics Society, v. 37, n. 8, p. 697-705, 1989. Disponível em: https://pubmed.ncbi.nlm.nih.gov/2754154/ DOI: https://doi.org/10.1111/j.1532-5415.1989.tb02230.x

REINHERR, F. W. et al. Factors affecting return of symptoms 1 year after treatment in a 62-week controlled study of fluoxetine in major depression. The Journal of clinical psychiatry, v. 62, n. 22, p. 16 – 23, 2001. Disponível em: https://pubmed.ncbi.nlm.nih.gov/11599643/

SERAFINI, G. et al. The use of antidepressant medications for Bipolar I and II disorders. Psychiatry Research, v. 296, p. 113273, 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32653094/ DOI: https://doi.org/10.1016/j.psychres.2020.113273

STRICKLAN, J. C. et al. The impact of financial strain on medication non-adherence: Influence of psychiatric medication use. Psychiatry Research, v. 271, p. 389 – 395, 2019. Disponível em: https://www.sciencedirect.com/science/article/abs/pii/S0165178118310825?via%3Dihub DOI: https://doi.org/10.1016/j.psychres.2018.11.055

VAN EERD, E. A. M. et al. Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial. The European respiratory journal, v. 49, n. 6 p. 1700561, jun. 2017. Disponível em: https://pubmed.ncbi.nlm.nih.gov/28642316/ DOI: https://doi.org/10.1183/13993003.00561-2017

VOELKER, J. et al. United States national trends in prevalence of major depressive episode and co-occurring suicidal ideation and treatment resistance among adults. Journal of Affective Disorders Reports, vol. 5, p. 100172, 2021. Disponível em: https://www.sciencedirect.com/science/article/pii/S2666915321000998 DOI: https://doi.org/10.1016/j.jadr.2021.100172

WARDEN, D. et al. Income and attrition in the treatment of depression: a STAR*D report. Depression and anxiety, v. 26, n. 7, p. 622 – 633, 2009. Disponível em: https://pubmed.ncbi.nlm.nih.gov/19582825/ DOI: https://doi.org/10.1002/da.20541

XIANG, Y. et al. Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China. Progress in neuro-psychopharmacology & biological psychiatry, v. 31, n. 3, p. 756 – 760, 2007. Disponível em: https://pubmed.ncbi.nlm.nih.gov/17289236/ DOI: https://doi.org/10.1016/j.pnpbp.2007.01.013

Published

2022-06-01

How to Cite

Cândido, M. M. ., & Nobre, M. S. de C. . (2022). PRESCRIPTION OF PSYCHOTROPIC DRUGS IN PATIENTS WITH HARMFUL SOCIOECONOMIC AND ENVIRONMENTAL CONDITIONS: A SYSTEMATIC REVIEW. Revista Contemporânea, 2(3), 794–813. https://doi.org/10.56083/RCV2N3-038

Issue

Section

Articles